Diagnósticos da América Future Growth
Future criteria checks 3/6
Diagnósticos da América is forecast to grow earnings and revenue by 92.7% and 7% per annum respectively. EPS is expected to grow by 98.1% per annum. Return on equity is forecast to be -1.5% in 3 years.
Key information
92.7%
Earnings growth rate
98.1%
EPS growth rate
Healthcare earnings growth | 26.4% |
Revenue growth rate | 7.0% |
Future return on equity | -1.5% |
Analyst coverage | Good |
Last updated | 23 Dec 2024 |
Recent future growth updates
Recent updates
Some Diagnósticos da América S.A. (BVMF:DASA3) Shareholders Look For Exit As Shares Take 27% Pounding
Nov 15Diagnósticos da América (BVMF:DASA3) Has Some Way To Go To Become A Multi-Bagger
Nov 13Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Benign Growth For Diagnósticos da América S.A. (BVMF:DASA3) Underpins Stock's 30% Plummet
Jun 24Why Investors Shouldn't Be Surprised By Diagnósticos da América S.A.'s (BVMF:DASA3) 25% Share Price Plunge
May 10Risks To Shareholder Returns Are Elevated At These Prices For Diagnósticos da América S.A. (BVMF:DASA3)
Mar 21Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Feb 04Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Jan 08Insufficient Growth At Diagnósticos da América S.A. (BVMF:DASA3) Hampers Share Price
Dec 18Diagnósticos da América (BVMF:DASA3) Is Reinvesting At Lower Rates Of Return
Sep 20Is Diagnósticos da América (BVMF:DASA3) Using Too Much Debt?
Aug 25Diagnósticos da América S.A. (BVMF:DASA3) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 27Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Apr 17Diagnósticos da América (BVMF:DASA3) Seems To Be Using A Lot Of Debt
Mar 13Returns On Capital At Diagnósticos da América (BVMF:DASA3) Paint A Concerning Picture
Dec 14Does Diagnósticos da América (BVMF:DASA3) Have A Healthy Balance Sheet?
Nov 09Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Aug 19Here's Why Diagnósticos da América (BVMF:DASA3) Has A Meaningful Debt Burden
Jul 15Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
May 06Results: Diagnósticos da América S.A. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Apr 01These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Reasonably Well
Mar 02Diagnósticos da América (BVMF:DASA3) Could Be Struggling To Allocate Capital
Jan 25Diagnósticos da América (BVMF:DASA3) Might Be Having Difficulty Using Its Capital Effectively
Oct 10Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Sep 13There Are Reasons To Feel Uneasy About Diagnósticos da América's (BVMF:DASA3) Returns On Capital
Jun 27Diagnósticos da América (BVMF:DASA3) Has A Somewhat Strained Balance Sheet
May 31We're Watching These Trends At Diagnósticos da América (BVMF:DASA3)
Feb 25Shareholders of Diagnósticos da América (BVMF:DASA3) Must Be Delighted With Their 634% Total Return
Jan 03These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Extensively
Dec 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 17,475 | 113 | N/A | N/A | 6 |
12/31/2025 | 16,432 | -204 | N/A | N/A | 8 |
12/31/2024 | 15,407 | -494 | N/A | N/A | 8 |
9/30/2024 | 14,971 | -879 | -805 | -234 | N/A |
6/30/2024 | 14,771 | -972 | -1,109 | -575 | N/A |
3/31/2024 | 14,446 | -1,150 | -1,209 | -487 | N/A |
12/31/2023 | 14,252 | -1,138 | -1,775 | -964 | N/A |
9/30/2023 | 14,213 | -843 | -1,320 | -367 | N/A |
6/30/2023 | 13,869 | -752 | -1,308 | -169 | N/A |
3/31/2023 | 13,527 | -590 | -1,369 | -223 | N/A |
12/31/2022 | 13,129 | -387 | -1,165 | -29 | N/A |
9/30/2022 | 12,523 | -340 | -523 | 428 | N/A |
6/30/2022 | 11,862 | -177 | -404 | 555 | N/A |
3/31/2022 | 11,178 | -177 | -181 | 724 | N/A |
12/31/2021 | 10,419 | -227 | 392 | 1,298 | N/A |
9/30/2021 | 9,973 | -36 | -17 | 819 | N/A |
6/30/2021 | 9,280 | -60 | -112 | 628 | N/A |
3/31/2021 | 7,959 | -85 | 157 | 903 | N/A |
12/31/2020 | 7,039 | -151 | 11 | 767 | N/A |
9/30/2020 | 5,887 | -191 | -210 | 469 | N/A |
6/30/2020 | 4,986 | -198 | 152 | 782 | N/A |
3/31/2020 | 4,795 | -19 | 312 | 827 | N/A |
12/31/2019 | 4,365 | 125 | 195 | 699 | N/A |
9/30/2019 | 4,238 | 127 | 493 | 925 | N/A |
6/30/2019 | 4,096 | 158 | 322 | 726 | N/A |
3/31/2019 | 3,992 | 168 | 208 | 553 | N/A |
12/31/2018 | 3,933 | 184 | 231 | 530 | N/A |
9/30/2018 | 3,886 | 210 | 78 | 386 | N/A |
6/30/2018 | 3,733 | 175 | N/A | 453 | N/A |
3/31/2018 | 3,545 | 136 | N/A | 516 | N/A |
12/31/2017 | 3,399 | 131 | N/A | 653 | N/A |
9/30/2017 | 3,259 | 129 | N/A | 626 | N/A |
6/30/2017 | 3,178 | 152 | N/A | 669 | N/A |
3/31/2017 | 3,138 | 169 | N/A | 733 | N/A |
12/31/2016 | 3,041 | 95 | N/A | 842 | N/A |
9/30/2016 | 2,965 | 90 | N/A | 676 | N/A |
6/30/2016 | 2,899 | 39 | N/A | 624 | N/A |
3/31/2016 | 2,864 | 29 | N/A | 531 | N/A |
12/31/2015 | 2,794 | 24 | N/A | 489 | N/A |
9/30/2015 | 2,731 | 4 | N/A | 433 | N/A |
6/30/2015 | 2,731 | 38 | N/A | 391 | N/A |
3/31/2015 | 2,691 | 58 | N/A | 387 | N/A |
12/31/2014 | 2,698 | 88 | N/A | 459 | N/A |
9/30/2014 | 2,666 | 135 | N/A | 462 | N/A |
6/30/2014 | 2,584 | 127 | N/A | 357 | N/A |
3/31/2014 | 2,528 | 130 | N/A | 319 | N/A |
12/31/2013 | 2,448 | 125 | N/A | 255 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DASA3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).
Earnings vs Market: DASA3 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DASA3 is expected to become profitable in the next 3 years.
Revenue vs Market: DASA3's revenue (7% per year) is forecast to grow slower than the BR market (7.8% per year).
High Growth Revenue: DASA3's revenue (7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DASA3 is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 05:20 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Diagnósticos da América S.A. is covered by 26 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
William Bertan | BB Banco de Investimento S.A. |
Flavio Yoshida | BofA Global Research |
Fred Mendes | BofA Global Research |